This federal contract award is a Delivery Order with a Firm Fixed Price of $68,649.37 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The contract covers the procurement of 4,566,768,608 REVLIMID 10 MG CAPSULE 28S and has an ultimate completion date of January 9, 2025.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
This specific contract award was not designated with any set-aside requirements, indicating open competition. The DLA, as the primary contracting agency, is responsible for providing medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Generated 3/18/25, 9:55 AM